Exciva, a biopharmaceutical company based in Heidelberg, has successfully closed a Series B funding round, raising €51 million ($59 million). The round was co-led by Gimv...
Alvotech Secures €100 Million Senior Term Loan Facility for Strategic Priorities Alvotech, a BioTech company based in Reykjavík, specializing in biosimilar medicines development and manufacture, has...
Each year, the renowned TechCrunch Startup Battlefield pitch competition attracts a multitude of hopeful applicants. From a pool of thousands, only the top 200 contenders are...
The Rapid Evolution of Biotechnology: Cell and Gene Therapy The field of biotechnology is experiencing a swift transformation, fueled by advancements in cell and gene therapy....
Subscribe to our weekly newsletter below and never miss the latest News or an exclusive offer.